Fig. 11From: A multifunctional platform with single-NIR-laser-triggered photothermal and NO release for synergistic therapy against multidrug-resistant Gram-negative bacteria and their biofilmsa 3T3 fibroblast viabilities treated with various concentrations of TG-NO-B at the indicated time points in vitro. b Hemocompatibilities of TG-NO-B at different concentrations. c H&E staining images of the major organs (heart, liver, spleen, lung, and kidney) from the mice 7 days and 28 days after intravenous injection of PBS or TG-NO-B at doses of 100 and 500 μg/mLBack to article page